Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.
Nautilus Biotechnology, Inc. Frequently Asked Questions
What is the ticker symbol for Nautilus Biotechnology, Inc.? What does NAUT stand for in stocks?
NAUT is the stock ticker symbol of Nautilus Biotechnology, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of Nautilus Biotechnology, Inc. (NAUT)?
As of Fri Dec 20 2024, market cap of Nautilus Biotechnology, Inc. is 220.99 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of NAUT stock?
You can check NAUT's fair value in chart for subscribers.
Is Nautilus Biotechnology, Inc. a good stock to buy?
The fair value guage provides a quick view whether NAUT is over valued or under valued. Whether Nautilus Biotechnology, Inc. is cheap or expensive depends on the assumptions which impact Nautilus Biotechnology, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NAUT.